Monash University spinout Rage Biotech on Thursday announced a $29 million Series A raise to advance development of an inhaled RNA therapy for chronic inflammatory lung disease. The company...
Three Victorian HealthTech startups have secured pre-seed funding from Breakthrough Victoria and Monash University, marking the official launch of a new $15 million fund and the university’s new commercialisation...